Skip to search formSkip to main contentSkip to account menu

Xanthinol Niacinate

Known as: Xantinol Nicotinate, 3-Pyridinecarboxylic acid, compd. with 3,7-dihydro-7-(2-hydroxy-3-((2-hydroxyethyl)methylamino)propyl)-1,3-dimethyl-1H-purine-2,6-dione (1:1), Nicotinate, Xanthinol 
A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Diffusion of two model drugs-benzyl nicotinate and ibuprofen-and the plasma macromolecule albumin across atherosclerotic rabbit… 
2001
2001
A 67‐year‐old woman was referred to our Department in January 1997 with an isomorphic Koebner response due to mesotherapy. 
Review
2000
Review
2000
AbstractObjective: To evaluate the role of orally administered vasoactive medication in the management of intermittent… 
1981
1981
The effect of food on absorption of d,1-alpha-tocopheryl nicotinate was studied in cross-over studies with eight beagle dogs and… 
1979
1979
SummaryThe effect of nicotinic acid and several derivatives on the nocturnal level of free fatty acids was studied in 12 healthy… 
1977
1977
Pentoxifylline--3,7-dimethyl-1(5-oxo-hexyl) xanthine--a new vasodilator compound, was tried in 28 cases of occlusive… 
1977
1977
A controlled, double-blind study of effects of dl-alpha-tocopheryl nicotinate (vitamin E-nicotinate: EN) for relief of symptoms… 
1971
1971
When incubated with 14C-nicotinic acid and phosphorylribose-1-pyrophosphate, human platelet lysate incorporates radioactivity…